In-situ Single-Molecule Investigations of the Impacts of Biochemical Perturbations on Conformational Intermediates of Monomeric α-Synuclein

-Synuclein aggregation is a common trait in synucleinopathies, including Parkinsons disease. Being an unstructured protein, -synuclein exists in several distinct conformational intermediates, contributing to both its function and pathogenesis. However, the regulation of these monomer conformations by biochemical factors and potential drugs has remained elusive. In this study, we devised an in-situ single-molecule manipulation approach to pinpoint kinetically stable conformational intermediates of monomeric -synuclein and explore the effects of various biochemical factors and drugs. We uncovered a partially folded conformation located in the non-amyloid-{beta} component (NAC) region of monomeric -synuclein, which is regulated by preNAC region. This conformational intermediate is sensitive to biochemical perturbations and small-molecule drugs that influencing -synucleins aggregation tendency. Our findings reveal that this partially folded intermediate may play a role in -synuclein aggregation, offering fresh perspectives for potential treatments aimed at the initial stage of higher-order -synuclein aggregation. The single-molecule approach developed here can be broadly applied to the study of disease-related intrinsically disordered proteins.